ArticleACS biomaterials science & engineering2025
Sensors Manufacturing on a 3D-Printed Transwell-Based Hybrid Organ-on-a-Chip for Non-Invasive Real-Time Biological Barrier Resistance Monitoring.
Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering graphene oxide interfaces for electrochemical biosensing of biomolecules, cells, and organoids.Nano convergence · 2026Review
- Construction, evaluation, and applications of renal barrier-on-a-chip system.Bioactive materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biological barriers in our body are dedicated to maintaining systemic homeostasis by enabling selective transport, the dysregulation of which plays a pathogenic role in several diseases. Transendothelial/epithelial electrical resistance (TEER) analysis is conventionally used to assess the barrier permeability. Engineering TEER setups within advanced in vitro models has become essential for acquiring real-time information on barrier integrity inside organ-on-a-chip (OOC) devices. However, current approaches often involve multiple assembly steps, require external access to the culture chamber, rely on cumbersome systems, or provide highly localized measurements that do not represent the entire surface of the tissue under examination. Specifically, in Transwell-based OOC systems, continuous and nondisruptive monitoring is often precluded by the need to disassemble the system for TEER measurement. To address these limitations, we combined conventional technology for patterning thin conductive films with low-cost, benchtop 3D printing to integrate planar electrodes within a Transwell-based hybrid OOC system. Our integrated TEER electrode device, ITE-MINERVA, can be easily employed with commercial measurement instruments, representing a useful tool for real-time, in situ detection of barrier functionality, potentially altered by drug toxicity and absorption processes, on Transwell-based OOCs, both in single- and multiorgan configurations, noninvasively and without stopping the experiment. In this work, we present the design and fabrication strategy of our innovative setup and its assessment in recording real-time TEER modulation on a Caco-2 cell-based in vitro gut epithelial barrier model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.